Hello @Helen67
Thank you for your question. I have checked with our policy team at BCNA and as you know Perjeta has only been approved in Australia for the treatment of HER 2 positive metastatic breast cancer. See thread below
https://www.bcna.org.au/understanding-breast-cancer/treatment/targeted-therapy/The policy team have suggested speaking with your medical oncologist regarding the treatment, maybe he/she can speak with Roche Australia to see if Perjeta may be available on compassionate grounds.
I found the following information regarding Perjeta treatment in early HER 2 positive breast cancer in the breastcancer.org site in the US
http://www.breastcancer.org/research-news/herceptin-w-perjeta-better-than-alone-for-somePlease follow through with your medical oncologist if you have further questions regarding your treatment.
Kind regards
